Table 2.
Ref. | Site | Age (yr) | Size (cm) | Weight (kg) | Immunohistochemical analysis (pos/neg) | Mitotic count | Local recurrence /metastases | Status at last follow-up |
Salem et al[11] | Omentum | 60 | 24 × 19 × 10 | 3.87 | CD34, CD99/(SMA), desmin, CD117 | 25/10HPF | No | NED |
4 mo | ||||||||
Patriti et al[12] | Greater omentum | 24 | 3.2 × 2.5 | NA | CD34, bcl-2/Pan cytokeratin reaction | 3/10HPF | No | NED |
2 yr | ||||||||
Mosquera et al[13] | Omentum | 40 | 9 | NA | CD34, CD99, p16/ EMA, cytokeratin, S-100, desmin, p53 | 9/10HPF | Yes | DOD |
34 mo | ||||||||
Ekıcı et al[14] | Lesser omentum | 51 | 11.5 × 8.5 × 7.5 | NA | CD 34/CD117, actin and S-100 | 0/10HPF | No | NED |
10 mo | ||||||||
Gold et al[15] | Omentum | NA | NA | NA | NA | NA | NA | NA |
NA: Not available; Neg: Negative; Pos: Positive; NED: No evidence of disease; DOD: Dead of disease; HPF: High-power fields; EMA: Epithelial membrane antigen; SMA: Smooth muscle actin.